Byproducts in the synthesis of [68Ga]Ga-PSMA-11
- PMID: 40251421
- DOI: 10.1038/s41596-025-01164-6
Byproducts in the synthesis of [68Ga]Ga-PSMA-11
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Similar articles
-
Reply to: Byproducts in the synthesis of [68Ga]Ga-PSMA-11.Nat Protoc. 2025 Apr 18. doi: 10.1038/s41596-025-01163-7. Online ahead of print. Nat Protoc. 2025. PMID: 40251422 No abstract available.
-
Optimization of synthesis conditions of [68Ga]Ga-PSMA-D5 and its clinical application in prostate cancer.Appl Radiat Isot. 2025 Jul;221:111825. doi: 10.1016/j.apradiso.2025.111825. Epub 2025 Apr 10. Appl Radiat Isot. 2025. PMID: 40228351
-
Evaluation of an Automated Module Synthesis and a Sterile Cold Kit-Based Preparation of 68Ga-PSMA-11 in Patients with Prostate Cancer.J Nucl Med. 2020 May;61(5):716-722. doi: 10.2967/jnumed.119.231605. Epub 2019 Oct 10. J Nucl Med. 2020. PMID: 31601704
-
Synthesis of 68Ga-radiopharmaceuticals using both generator-derived and cyclotron-produced 68Ga as exemplified by [68Ga]Ga-PSMA-11 for prostate cancer PET imaging.Nat Protoc. 2022 Apr;17(4):980-1003. doi: 10.1038/s41596-021-00662-7. Epub 2022 Mar 4. Nat Protoc. 2022. PMID: 35246649 Review.
-
Head-To-Head Comparison of 68Ga-PSMA-11 PET/CT and 99mTc-MDP Bone Scintigraphy for the Detection of Bone Metastases in Patients With Prostate Cancer: A Meta-Analysis.AJR Am J Roentgenol. 2022 Sep;219(3):386-395. doi: 10.2214/AJR.21.27323. Epub 2022 Apr 20. AJR Am J Roentgenol. 2022. PMID: 35441529 Review.
Cited by
-
Exploring the effect and mechanism of fucoidan on liver cancer depending on network pharmacology and experimental verification.Front Chem. 2025 Jul 16;13:1638785. doi: 10.3389/fchem.2025.1638785. eCollection 2025. Front Chem. 2025. PMID: 40740310 Free PMC article.
-
Integrated computational and experimental identification of N-[(1H-1,2,4-triazol-3-yl)phenyl]-1-(1H-pyrazolo[3,4-b]pyridin-3-yl)methanamide as a potent and selective TIM-3 inhibitor for NSCLC immunotherapy.Front Chem. 2025 Jun 9;13:1622511. doi: 10.3389/fchem.2025.1622511. eCollection 2025. Front Chem. 2025. PMID: 40552075 Free PMC article.
-
HIF1A acts as target of XiHuang Pill in the treatment of papillary thyroid cancer by regulating dedifferentiation.Front Chem. 2025 Jun 9;13:1607067. doi: 10.3389/fchem.2025.1607067. eCollection 2025. Front Chem. 2025. PMID: 40552073 Free PMC article.
-
Evaluation of newly synthesized schiff base Pd(II) complexes for prostate cancer treatment through in vitro cytotoxicity and molecular mechanistic studies.Front Chem. 2025 Jul 17;13:1636477. doi: 10.3389/fchem.2025.1636477. eCollection 2025. Front Chem. 2025. PMID: 40747210 Free PMC article.
References
-
- Eder, M. et al. Novel preclinical and radiopharmaceutical aspects of [68Ga]Ga-PSMA-HBED-CC: a new PET tracer for imaging of prostate cancer. Pharmaceuticals 7, 779–796 (2014).
-
- Ioppolo, J. A., Alvarez de Eulate, E., Cullen, D. R., Mohamed, S. & Morandeau, L. Development of a high‐performance liquid chromatography method for rapid radiochemical purity measurement of [18F]PSMA‐1007, a PET radiopharmaceutical for detection of prostate cancer. J. Label. Compd. Radiopharm. 66, 58–72 (2023). - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous